Nepal Healthcare Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nepal Healthcare Times.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 6, 2026

Mar. 6, 2026

Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.

GlobeNewswire

Mar. 6, 2026

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

The ROOT Brands Announces New Collaboration with Mammoth Nation, Expanding Access to Premium Wellness Products for America First Shoppers

GlobeNewswire

Mar. 6, 2026

Karylief Tinnitus Supplement Claims Evaluated: 2026 Consumer Report Examines Karylief Hearing Support Ingredients, Proprietary Blend Transparency, and Research Context

GlobeNewswire

Mar. 6, 2026

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

Crescent Biopharma Announces Grants of Inducement Awards

GlobeNewswire

Mar. 6, 2026

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

GlobeNewswire

Mar. 6, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

CAMP4 to Participate in Upcoming Investor Conferences

GlobeNewswire

Mar. 6, 2026

Galapagos Creates New Subscription Right Plan

GlobeNewswire

Mar. 6, 2026

Galapagos creëert nieuw inschrijvingsrechtenplan

GlobeNewswire

Mar. 6, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

Harvard Bioscience Announces Reverse Stock Split

GlobeNewswire

Mar. 6, 2026

Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds

GlobeNewswire

Mar. 6, 2026

Letter to Shareholders from CEO Dr. Ryan Saadi

GlobeNewswire

Mar. 6, 2026

Dermalogic Laser Center Launches New, Upgraded Website

GlobeNewswire

Mar. 6, 2026

Tris Pharma Announces Positive Debut Data from Phase 3 ALLEVIATE-1 and 2 Trials Evaluating Cebranopadol in Acute Pain at AAPM PainConnect 2026 Annual Meeting

GlobeNewswire